Spire Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History

Spire Wealth Management

$3.02 Billion
Q1 2025

A detailed history of Spire Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 180 shares of REGN stock, worth $87,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares

180

Previous 158 13.92%

Holding current value

$87,814

Previous $112,000 1.79%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	BUY	$634.14 - $744.83 $13,951 - $16,386	22 Added 13.92%	180 $114,000
Q4 2024 Jan 24, 2025	BUY	$701.85 - $1046.91 $9,124 - $13,609	13 Added 8.97%	158 $112,000
Q3 2024 Oct 15, 2024	BUY	$1024.09 - $1201.76 $29,698 - $34,851	29 Added 25.0%	145 $152,000
Q2 2024 Jul 31, 2024	SELL	$883.2 - $1071.19 $54,758 - $66,413	-62 Reduced 34.83%	116 $121,000
Q1 2024 Apr 24, 2024	SELL	$902.69 - $993.35 $7,221 - $7,946	-8 Reduced 4.3%	178 $171,000
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $3,875 - $4,408	-5 Reduced 2.62%	186 $163,000
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $6.06 Million - $7.39 Million	-8,756 Reduced 97.87%	191 $157,000
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $111,304 - $132,025	159 Added 1.81%	8,947 $6.43 Million
Q1 2023 May 09, 2023	BUY	$680.49 - $826.97 $5.88 Million - $7.14 Million	8,639 Added 5797.99%	8,788 $7.22 Million
Q4 2022 Feb 03, 2023	BUY	$705.89 - $766.39 $40,235 - $43,684	57 Added 61.96%	149 $108,000
Q3 2022 Nov 07, 2022	SELL	$573.97 - $724.32 $286,411 - $361,435	-499 Reduced 84.43%	92 $63,000
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $54,835 - $73,884	-100 Reduced 14.47%	591 $349,000
Q1 2022 Apr 18, 2022	SELL	$595.12 - $698.43 $85,697 - $100,573	-144 Reduced 17.25%	691 $483,000
Q4 2021 Jan 14, 2022	BUY	$543.48 - $670.97 $86,413 - $106,684	159 Added 23.52%	835 $527,000
Q3 2021 Oct 22, 2021	BUY	$574.03 - $680.96 $256,017 - $303,708	446 Added 193.91%	676 $410,000
Q2 2021 Jul 26, 2021	SELL	$472.8 - $558.54 $101,179 - $119,527	-214 Reduced 48.2%	230 $128,000
Q1 2021 May 21, 2021	BUY	$446.73 - $548.2 $198,348 - $243,400	444 New	444 $211,000

Others Institutions Holding REGN

# of Institutions

1,471

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $52.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Account

Spire Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History